Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Shmuel Yaccoby

Concepts (353)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
70
2023
3049
5.580
Why?
Osteoclasts
17
2015
469
2.720
Why?
Bone Diseases
7
2014
108
2.420
Why?
Gene Expression Regulation, Neoplastic
14
2018
868
1.820
Why?
Osteoblasts
13
2012
514
1.540
Why?
Neoplasm Proteins
7
2018
360
1.370
Why?
Osteolysis
6
2013
87
1.320
Why?
Boronic Acids
13
2013
197
1.310
Why?
Mice, SCID
21
2015
196
1.260
Why?
Coculture Techniques
12
2015
159
1.260
Why?
Bone Marrow
10
2018
414
1.140
Why?
Bone Neoplasms
3
2014
193
1.060
Why?
Cell Differentiation
14
2018
720
1.010
Why?
Bone and Bones
9
2014
515
1.000
Why?
Pyrazines
12
2013
203
0.990
Why?
Proteoglycans
6
2008
96
0.940
Why?
Protein-Tyrosine Kinases
2
2014
101
0.910
Why?
Bone Marrow Cells
5
2015
232
0.890
Why?
Mice
30
2015
6428
0.870
Why?
Cell Proliferation
11
2023
1097
0.840
Why?
Cell Communication
3
2015
72
0.810
Why?
Neoplastic Stem Cells
2
2017
104
0.810
Why?
Osteogenesis
5
2012
377
0.730
Why?
Membrane Glycoproteins
8
2009
270
0.720
Why?
Cell Movement
6
2014
271
0.710
Why?
Bone Resorption
4
2011
328
0.700
Why?
Intercellular Signaling Peptides and Proteins
3
2010
122
0.700
Why?
Adipocytes
2
2018
128
0.680
Why?
Animals
33
2016
14402
0.680
Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
11
0.680
Why?
Antineoplastic Agents
10
2015
1300
0.630
Why?
Humans
70
2023
54304
0.620
Why?
Gene Expression
3
2018
664
0.610
Why?
Gene Expression Regulation, Enzymologic
2
2017
205
0.580
Why?
Gene Expression Profiling
9
2023
1141
0.580
Why?
Tumor Microenvironment
2
2015
210
0.570
Why?
Protease Inhibitors
4
2010
64
0.560
Why?
Cell Survival
9
2015
657
0.550
Why?
Plasma Cells
8
2012
239
0.540
Why?
Cytokines
3
2015
677
0.510
Why?
Cysteine-Rich Protein 61
1
2014
4
0.500
Why?
Disease Models, Animal
8
2016
1651
0.500
Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.460
Why?
Mesenchymal Stem Cell Transplantation
1
2012
19
0.430
Why?
Cell Line, Tumor
10
2015
1551
0.420
Why?
Rabbits
6
2013
425
0.420
Why?
Wnt Proteins
2
2010
110
0.400
Why?
Up-Regulation
3
2013
509
0.400
Why?
Parathyroid Hormone
4
2010
196
0.390
Why?
Angiogenesis Inhibitors
2
2010
203
0.390
Why?
Thalidomide
7
2016
398
0.380
Why?
Signal Transduction
6
2013
1751
0.360
Why?
Receptor, EphB4
1
2009
5
0.360
Why?
Ephrin-B2
1
2009
6
0.350
Why?
Fenretinide
1
2009
5
0.350
Why?
Antineoplastic Combined Chemotherapy Protocols
9
2016
1060
0.350
Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2009
8
0.350
Why?
Placenta
1
2011
136
0.350
Why?
Dipeptides
1
2009
20
0.350
Why?
Cell Adhesion Molecules
1
2009
87
0.340
Why?
Disease Progression
8
2014
915
0.340
Why?
Models, Biological
4
2010
825
0.330
Why?
Bone Development
1
2009
69
0.320
Why?
Tumor Necrosis Factor Ligand Superfamily Member 13
1
2007
3
0.320
Why?
Transmembrane Activator and CAML Interactor Protein
1
2007
3
0.320
Why?
Extracellular Matrix Proteins
1
2008
75
0.310
Why?
Apoptosis
8
2012
1302
0.300
Why?
Recombinant Fusion Proteins
1
2007
206
0.300
Why?
Bone Remodeling
4
2012
176
0.300
Why?
Prognosis
12
2018
2126
0.290
Why?
Melphalan
3
2016
184
0.290
Why?
Tumor Cells, Cultured
8
2013
477
0.280
Why?
Neoplasm Recurrence, Local
3
2023
645
0.280
Why?
Antibodies
1
2006
178
0.270
Why?
Immunohistochemistry
5
2015
1090
0.270
Why?
Serine Endopeptidases
1
2006
57
0.270
Why?
RNA, Small Interfering
4
2013
253
0.270
Why?
Antigens, Neoplasm
1
2006
170
0.260
Why?
Severe Combined Immunodeficiency
1
2005
12
0.260
Why?
Transplantation, Heterologous
5
2009
76
0.250
Why?
Alkaline Phosphatase
6
2017
99
0.250
Why?
Syndecan-1
6
2007
82
0.250
Why?
NF-kappa B
4
2013
336
0.240
Why?
Receptors, CXCR4
2
2014
31
0.240
Why?
Hematopoietic Stem Cells
3
2012
215
0.240
Why?
Gene Knockdown Techniques
2
2014
125
0.230
Why?
Flow Cytometry
6
2015
547
0.230
Why?
Bone Density
3
2010
416
0.220
Why?
Killer Cells, Natural
2
2015
106
0.220
Why?
Positron-Emission Tomography
2
2017
323
0.220
Why?
Translocation, Genetic
2
2021
287
0.220
Why?
Stromal Cells
1
2003
79
0.220
Why?
Immunotherapy, Adoptive
2
2015
134
0.210
Why?
Neoplasm Transplantation
3
2014
94
0.210
Why?
Transcription Factors
2
2023
622
0.210
Why?
Immunophenotyping
2
2015
117
0.210
Why?
Female
21
2018
28457
0.210
Why?
Neovascularization, Pathologic
3
2009
168
0.200
Why?
Epigenomics
1
2021
67
0.200
Why?
Immunoglobulin Light Chains
2
2015
101
0.200
Why?
T-Lymphocytes
2
2015
374
0.200
Why?
Cell Line
2
2015
1152
0.200
Why?
Decorin
2
2012
6
0.190
Why?
Oligonucleotide Array Sequence Analysis
4
2015
474
0.180
Why?
Antibodies, Monoclonal
4
2016
564
0.180
Why?
Drug Resistance, Neoplasm
2
2015
309
0.180
Why?
Syndecans
5
2006
43
0.180
Why?
Neoplasm Metastasis
2
2014
252
0.180
Why?
Cells, Cultured
4
2013
1737
0.170
Why?
Genes, myc
1
2019
47
0.170
Why?
Cell Division
4
2004
330
0.170
Why?
Cell Adhesion
2
2014
171
0.170
Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2015
674
0.160
Why?
Cyclin-Dependent Kinases
2
2015
35
0.160
Why?
Male
17
2018
27335
0.150
Why?
Risk Factors
5
2018
3934
0.150
Why?
Mice, Transgenic
4
2007
658
0.150
Why?
Diffusion Magnetic Resonance Imaging
1
2018
128
0.150
Why?
Hexokinase
1
2017
18
0.150
Why?
Monoclonal Gammopathy of Undetermined Significance
2
2018
108
0.150
Why?
Chromosomes, Human, Pair 17
1
2017
43
0.150
Why?
Calcification, Physiologic
1
2017
42
0.150
Why?
Tumor Suppressor Protein p53
2
2017
251
0.150
Why?
Disease-Free Survival
5
2018
488
0.150
Why?
Chromosome Aberrations
3
2016
316
0.150
Why?
Proteasome Inhibitors
2
2016
111
0.150
Why?
Pelvis
1
2017
77
0.140
Why?
Chromosome Deletion
1
2017
150
0.140
Why?
Stem Cells
2
2009
194
0.140
Why?
Neoplasm, Residual
1
2017
167
0.140
Why?
Pyridinium Compounds
1
2015
17
0.140
Why?
Neoplasms, Experimental
2
2007
115
0.140
Why?
Recurrence
3
2014
692
0.140
Why?
Biopsy
2
2018
693
0.140
Why?
Base Sequence
2
2008
719
0.140
Why?
Homologous Recombination
1
2015
43
0.130
Why?
Xenograft Model Antitumor Assays
3
2015
219
0.130
Why?
Fluorodeoxyglucose F18
1
2017
212
0.130
Why?
Benzimidazoles
1
2015
54
0.130
Why?
Peptide Nucleic Acids
1
2015
17
0.130
Why?
Endothelial Cells
2
2009
294
0.130
Why?
Rad51 Recombinase
1
2015
21
0.130
Why?
Genes, Neoplasm
1
2015
36
0.130
Why?
Bromodeoxyuridine
2
2005
20
0.130
Why?
Aged
11
2017
10054
0.130
Why?
Immunologic Factors
1
2016
130
0.130
Why?
Genomic Instability
1
2015
95
0.130
Why?
Asymptomatic Diseases
1
2014
43
0.120
Why?
Antigens, CD
1
2015
242
0.120
Why?
Carrier Proteins
4
2008
360
0.120
Why?
Time Factors
7
2017
3207
0.120
Why?
Proteome
1
2015
178
0.120
Why?
Immunotherapy
1
2016
264
0.120
Why?
Nicotinamide Mononucleotide
1
2013
4
0.110
Why?
Acrylamides
1
2013
8
0.110
Why?
Antigens, CD19
2
2005
19
0.110
Why?
Interleukin-6
2
2005
315
0.110
Why?
Chemokine CXCL12
1
2013
31
0.110
Why?
NAD
1
2013
46
0.110
Why?
Niacinamide
1
2013
25
0.110
Why?
Poly(ADP-ribose) Polymerases
1
2013
43
0.110
Why?
Enzyme Induction
1
2013
80
0.110
Why?
Sirtuin 1
1
2013
29
0.110
Why?
Amides
1
2013
43
0.110
Why?
beta Catenin
1
2013
102
0.110
Why?
Oligopeptides
1
2013
95
0.110
Why?
Tumor Burden
2
2010
141
0.110
Why?
Nitriles
1
2013
69
0.110
Why?
Leukemia
1
2013
69
0.110
Why?
Myelodysplastic Syndromes
1
2013
79
0.110
Why?
Proteomics
1
2015
343
0.110
Why?
Middle Aged
11
2018
13076
0.110
Why?
Enzyme Inhibitors
2
2013
445
0.110
Why?
Magnetic Resonance Imaging
2
2012
1616
0.110
Why?
Injections, Intravenous
1
2012
148
0.110
Why?
Piperidines
1
2013
103
0.110
Why?
Proto-Oncogene Proteins c-jun
2
2009
83
0.110
Why?
Myeloma Proteins
2
2004
26
0.110
Why?
Cytotoxicity, Immunologic
1
2012
62
0.110
Why?
Remission Induction
1
2012
222
0.100
Why?
Neoplasm Staging
3
2015
805
0.100
Why?
RNA, Messenger
3
2015
1203
0.100
Why?
Anti-Inflammatory Agents
1
2012
175
0.100
Why?
Renal Insufficiency
1
2012
138
0.100
Why?
Glycoproteins
2
2001
132
0.090
Why?
beta 2-Microglobulin
2
2007
35
0.090
Why?
Lymph Nodes
1
2012
284
0.090
Why?
JNK Mitogen-Activated Protein Kinases
2
2007
78
0.090
Why?
Early Growth Response Protein 1
1
2009
39
0.090
Why?
Dexamethasone
3
2007
435
0.090
Why?
Myocardium
1
2012
443
0.090
Why?
Sphingosine
1
2009
27
0.090
Why?
Lysophospholipids
1
2009
34
0.090
Why?
Bone Transplantation
2
2010
55
0.090
Why?
Organoids
1
2009
41
0.080
Why?
Drug Screening Assays, Antitumor
1
2009
142
0.080
Why?
p38 Mitogen-Activated Protein Kinases
1
2009
99
0.080
Why?
Leukocytes, Mononuclear
1
2009
133
0.080
Why?
Caspases
1
2009
146
0.080
Why?
Enzyme Activation
1
2009
328
0.080
Why?
Glucuronidase
2
2007
48
0.080
Why?
Prospective Studies
5
2016
2604
0.080
Why?
Wnt3 Protein
1
2008
8
0.080
Why?
Lentivirus
1
2008
18
0.080
Why?
Wnt3A Protein
1
2008
13
0.080
Why?
Ellipticines
1
2008
6
0.080
Why?
B-Cell Activating Factor
1
2007
3
0.080
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
93
0.080
Why?
Bone Density Conservation Agents
1
2009
82
0.080
Why?
Cytological Techniques
1
2007
15
0.080
Why?
Diploidy
1
2007
30
0.080
Why?
Precancerous Conditions
1
2008
93
0.080
Why?
Genetic Vectors
1
2008
139
0.080
Why?
Karyotyping
1
2007
92
0.080
Why?
RNA Interference
1
2008
195
0.080
Why?
Heparan Sulfate Proteoglycans
1
2007
14
0.080
Why?
Diphosphonates
1
2008
96
0.080
Why?
Phosphorylation
1
2009
613
0.080
Why?
Hematopoietic Stem Cell Transplantation
1
2012
583
0.070
Why?
Receptor Activator of Nuclear Factor-kappa B
2
2004
32
0.070
Why?
Reactive Oxygen Species
1
2009
491
0.070
Why?
Models, Animal
1
2007
254
0.070
Why?
Mice, Inbred C57BL
1
2012
2002
0.070
Why?
Kidney
1
2012
821
0.070
Why?
Phenotype
2
2009
820
0.070
Why?
Immunosuppressive Agents
1
2008
248
0.070
Why?
Gelatinases
1
2006
36
0.070
Why?
Treatment Outcome
6
2017
5609
0.070
Why?
Endopeptidases
1
2006
75
0.070
Why?
Risk Assessment
3
2018
1361
0.070
Why?
Antigens, CD34
1
2005
80
0.070
Why?
Survival Analysis
2
2018
736
0.070
Why?
RANK Ligand
2
2004
183
0.070
Why?
Adult
6
2018
14189
0.070
Why?
Fetal Tissue Transplantation
1
2005
7
0.070
Why?
Hematologic Neoplasms
1
2006
100
0.060
Why?
Metaphase
2
2016
55
0.060
Why?
Annexin A5
1
2004
14
0.060
Why?
Culture Media, Conditioned
1
2004
52
0.060
Why?
Phagocytosis
1
2004
51
0.060
Why?
Molecular Sequence Data
1
2006
980
0.060
Why?
Endothelium, Vascular
1
2006
288
0.060
Why?
Survival Rate
2
2018
954
0.060
Why?
Clinical Trials as Topic
3
2016
490
0.060
Why?
Membrane Proteins
1
2006
389
0.060
Why?
Pregnancy
1
2011
2637
0.060
Why?
Polymerase Chain Reaction
1
2005
531
0.060
Why?
Blotting, Western
2
2015
684
0.050
Why?
Oncogenes
1
2021
63
0.050
Why?
Oxidative Stress
1
2007
956
0.050
Why?
Combined Modality Therapy
2
2016
693
0.050
Why?
Polycomb Repressive Complex 2
1
2021
50
0.050
Why?
Cell Polarity
1
2000
19
0.050
Why?
Chromatin
1
2021
156
0.050
Why?
Cell Transplantation
1
1999
4
0.050
Why?
Mice, Inbred ICR
1
1999
25
0.050
Why?
Protein Disulfide-Isomerases
1
2019
15
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
14
0.040
Why?
Histones
1
2021
335
0.040
Why?
Cell Membrane
1
2000
279
0.040
Why?
Radiation Chimera
1
1998
5
0.040
Why?
Osteoprotegerin
3
2006
57
0.040
Why?
Clone Cells
1
1998
89
0.040
Why?
Dose-Response Relationship, Drug
2
2016
1476
0.040
Why?
Multivariate Analysis
2
2012
643
0.040
Why?
Radiography
2
2012
526
0.040
Why?
In Situ Hybridization, Fluorescence
1
2019
278
0.040
Why?
Aged, 80 and over
2
2017
3430
0.040
Why?
DNA-Binding Proteins
1
2021
462
0.040
Why?
False Positive Reactions
1
2017
68
0.040
Why?
Tomography, X-Ray Computed
2
2017
1222
0.040
Why?
Indolizines
1
2015
11
0.030
Why?
Cyclic N-Oxides
1
2015
15
0.030
Why?
Imaging, Three-Dimensional
1
2017
172
0.030
Why?
S Phase
1
2015
19
0.030
Why?
Drug Synergism
1
2015
171
0.030
Why?
Genes, BRCA1
1
2015
24
0.030
Why?
Transcriptome
1
2018
346
0.030
Why?
Follow-Up Studies
2
2013
2389
0.030
Why?
Real-Time Polymerase Chain Reaction
1
2015
206
0.030
Why?
Enzyme-Linked Immunosorbent Assay
1
2015
314
0.030
Why?
Predictive Value of Tests
2
2007
1044
0.030
Why?
Transcription, Genetic
1
2015
418
0.030
Why?
DNA Damage
1
2015
357
0.030
Why?
Transfection
2
2004
399
0.030
Why?
Interleukin Receptor Common gamma Subunit
1
2012
10
0.030
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
11
0.030
Why?
Interleukin-2
1
2012
75
0.030
Why?
Mice, Inbred NOD
1
2012
99
0.030
Why?
Acute Disease
1
2013
403
0.030
Why?
Immunoenzyme Techniques
1
2012
166
0.030
Why?
Creatinine
1
2012
169
0.030
Why?
Glomerular Filtration Rate
1
2012
139
0.030
Why?
Lymphocyte Activation
1
2012
197
0.020
Why?
Receptors, Tumor Necrosis Factor
2
2001
36
0.020
Why?
C-Reactive Protein
1
2012
159
0.020
Why?
Receptors, Cytoplasmic and Nuclear
2
2001
85
0.020
Why?
Proportional Hazards Models
1
2012
430
0.020
Why?
Radiation-Sensitizing Agents
1
2010
55
0.020
Why?
Inhibitor of Apoptosis Proteins
1
2009
21
0.020
Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
15
0.020
Why?
Incidence
1
2013
1083
0.020
Why?
Protein Transport
1
2010
195
0.020
Why?
Microtubule-Associated Proteins
1
2009
78
0.020
Why?
Peptides
1
2010
276
0.020
Why?
CDC2-CDC28 Kinases
1
2008
15
0.020
Why?
Down-Regulation
1
2009
388
0.020
Why?
Salvage Therapy
1
2008
145
0.020
Why?
Antibodies, Monoclonal, Humanized
1
2009
240
0.020
Why?
Protein Binding
1
2009
736
0.020
Why?
Antineoplastic Agents, Hormonal
1
2007
49
0.020
Why?
Phospholipase C gamma
1
2006
4
0.020
Why?
Proteins
1
2010
376
0.020
Why?
Cytogenetic Analysis
1
2007
90
0.020
Why?
Caspase 9
1
2006
20
0.020
Why?
Chi-Square Distribution
1
2007
318
0.020
Why?
Mitogen-Activated Protein Kinase 3
1
2006
55
0.020
Why?
Retrospective Studies
2
2012
6462
0.020
Why?
Cyclin D
1
2006
20
0.020
Why?
Cell Cycle
1
2008
275
0.020
Why?
RNA, Neoplasm
1
2006
54
0.020
Why?
src-Family Kinases
1
2006
54
0.020
Why?
Cyclins
1
2006
54
0.020
Why?
Bone Marrow Transplantation
1
2007
149
0.020
Why?
Case-Control Studies
1
2009
1229
0.020
Why?
Chromosome Mapping
1
2006
175
0.020
Why?
Proto-Oncogene Proteins c-akt
1
2006
176
0.020
Why?
Phosphatidylinositol 3-Kinases
1
2006
153
0.020
Why?
Mice, Inbred BALB C
1
2006
371
0.020
Why?
Cluster Analysis
1
2006
244
0.020
Why?
Data Interpretation, Statistical
1
2006
173
0.020
Why?
Kaplan-Meier Estimate
1
2007
514
0.020
Why?
Transplantation, Autologous
1
2007
485
0.020
Why?
DNA, Complementary
1
2004
145
0.020
Why?
Logistic Models
1
2007
991
0.020
Why?
Young Adult
1
2013
4313
0.010
Why?
Recombinant Proteins
1
2004
570
0.010
Why?
Randomized Controlled Trials as Topic
1
2005
580
0.010
Why?
Solubility
1
2002
74
0.010
Why?
Leukemia, Plasma Cell
1
2002
34
0.010
Why?
Acid Phosphatase
1
2001
15
0.010
Why?
Protein Structure, Tertiary
1
2002
289
0.010
Why?
Neoplasm Invasiveness
1
2002
294
0.010
Why?
Hodgkin Disease
1
2001
51
0.010
Why?
Adolescent
1
2013
6896
0.010
Why?
Isoenzymes
1
2001
176
0.010
Why?
LDL-Receptor Related Protein-Associated Protein
1
2000
2
0.010
Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2001
70
0.010
Why?
Paraproteinemias
1
2001
80
0.010
Why?
Hepatocyte Growth Factor
1
2000
14
0.010
Why?
Reference Values
1
2001
353
0.010
Why?
Intercellular Adhesion Molecule-1
1
2000
75
0.010
Why?
Epithelial Cells
1
2000
255
0.010
Why?
Yaccoby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description